(Q40971240)

25 September 2017

title

Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS (English)

1 reference

https://api.crossref.org/works/10.1002/EJI.1830251019

28 May 2024

0 references

1

K. J. Maloy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589080

28 May 2024

3

A. M. Mowat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589080

28 May 2024

author name string

A. M. Donachie

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589080

28 May 2024

language of work or name

English

0 references

publication date

1 October 1995

1 reference

full work available at URL

25 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Feji.1830251019

1 reference

https://api.crossref.org/works/10.1002/EJI.1830251019

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.1830251019

28 May 2024

1 reference

https://api.crossref.org/works/10.1002/EJI.1830251019

European Journal of Immunology

28 May 2024

published in

1 reference

25 September 2017

volume

25

1 reference

25 September 2017

issue

10

1 reference

25 September 2017

page(s)

2835-2841

1 reference

The mucosal immune system: from fundamental concepts to vaccine development

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251019

7 January 2021

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251019

7 January 2021

ISCOMS — a novel strategy for mucosal immunization?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251019

7 January 2021

Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization aga

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251019

7 January 2021

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251019

7 January 2021

Increased immunogenicity of a non-amphipathic protein (BSA) after inclusion into iscoms

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251019

7 January 2021

The iscom structure as an immune-enhancing moiety: experience with viral systems

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251019

7 January 2021

Initiation of cytotoxic T-cell response and protection of Balb/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251019

7 January 2021

Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with iscoms and/or matrix.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251019

7 January 2021

The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251019

7 January 2021

Involvement of interleukin-2 and interferon-gamma in the immune response induced by influenza virus iscoms

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251019

7 January 2021

Mucosal immunity to infection with implications for vaccine development

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830251019

7 January 2021

4

1

49

Morein B.

1990

1 reference

https://api.crossref.org/works/10.1002/EJI.1830251019

28 May 2024

Identifiers

1 reference

25 September 2017

1 reference